Have a feature idea you'd love to see implemented? Let us know!

MD Mednax Inc

  1. Stocks
  2. Healthcare
  3. NYSE: MD

Price (delayed)

$12.77

Market cap

$1.1B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.04

Enterprise value

$1.78B

Mednax, Inc. is a national medical group comprised of the nation's leading providers of physician services. Physicians and advanced practitioners practicing as part of Mednax are reshaping the delivery of ...

Highlights
The debt has decreased by 10% from the previous quarter and by 6% YoY
The quick ratio has declined by 19% since the previous quarter but it has grown by 12% year-on-year
The equity is down by 25% YoY and by 17% QoQ
The gross margin has declined by 7% year-on-year
Sector: Healthcare
Industry: Medical Care Facilities
Website: http://www.mednax.com
Peers: THC UHS CYH

Key stats

What are the main financial stats of MD
Market
Shares outstanding
85.87M
Market cap
$1.1B
Enterprise value
$1.78B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.52
Price to sales (P/S)
0.53
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.89
Earnings
Revenue
$2B
EBIT
-$226.56M
EBITDA
-$189.19M
Free cash flow
$100.42M
Per share
EPS
-$3.04
Free cash flow per share
$1.21
Book value per share
$8.4
Revenue per share
$24.03
TBVPS
$8.95
Balance sheet
Total assets
$2B
Total liabilities
$1.29B
Debt
$698.31M
Equity
$706.46M
Working capital
$119.06M
Liquidity
Debt to equity
0.99
Current ratio
1.38
Quick ratio
1.31
Net debt/EBITDA
-3.59
Margins
EBITDA margin
-9.4%
Gross margin
20.8%
Net margin
-12.6%
Operating margin
-10.1%
Efficiency
Return on assets
-11.6%
Return on equity
-29.8%
Return on invested capital
-19.9%
Return on capital employed
-13.4%
Return on sales
-11.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MD stock price

How has the Mednax stock price performed over time
Intraday
0.31%
1 week
3.91%
1 month
20.93%
1 year
1.19%
YTD
37.31%
QTD
10.18%

Financial performance

How have Mednax's revenue and profit performed over time
Revenue
$2B
Gross profit
$417.05M
Operating income
-$202.18M
Net income
-$251.89M
Gross margin
20.8%
Net margin
-12.6%
The gross margin has declined by 7% year-on-year
Mednax's gross profit has decreased by 6% YoY

Growth

What is Mednax's growth rate over time

Valuation

What is Mednax stock price valuation
MD P/E details
P/E
N/A
P/B
1.52
P/S
0.53
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.89
The P/B is 52% above the last 4 quarters average of 1.0 but 16% below the 5-year quarterly average of 1.8
The equity is down by 25% YoY and by 17% QoQ
The stock's price to sales (P/S) is 34% less than its 5-year quarterly average of 0.8 but 33% more than its last 4 quarters average of 0.4

Efficiency

How efficient is Mednax business performance

Dividends

What is MD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MD.

Financial health

How did Mednax financials performed over time
The total assets is 55% greater than the total liabilities
The company's current ratio fell by 20% QoQ but it rose by 11% YoY
The quick ratio has declined by 19% since the previous quarter but it has grown by 12% year-on-year
The equity is down by 25% YoY and by 17% QoQ
MD's debt to equity is up by 25% year-on-year and by 9% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.